Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.
Filter results of approved projects table below
| Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
|---|---|---|---|---|---|
| Use of Breast Cancer Risk Reducing Medications | Paul Pinsky | National Institutes of Health | PLCO | Nov 19, 2024 | PLCO-1749 |
| Detection of lung disease using deep learning | Himanshu Joshi | Drongo AI pvt LTD | PLCO | Nov 15, 2024 | PLCOI-1747 |
| Exploring Multimodal Factors Influencing Breast Cancer Risk: A Data-Driven Approach | Oliver Díaz | Universitat de Barcelona | PLCO | Nov 12, 2024 | PLCO-1742 |
| A Hybridized machine learning based survival prediction of ovarian cyst | Ovoh Oghenefego | Delta State University Abraka | PLCO | Nov 12, 2024 | PLCO-1740 |
| Identifying Survival Phenotypes in High-Grade Serous Ovarian Cancer by Application of AI to Digital Pathology | Ernst Lengyel | University of Chicago | PLCO | Nov 12, 2024 | PLCOI-1737 |
| Prostate Cancer Screening using Machine Learning | Jerry John Rawlings Mensah | Virginia Commonwealth University | PLCO | Nov 5, 2024 | PLCO-1732 |
| Science Fair | Caspar McNulty | Swanson Middle School | PLCO | Nov 5, 2024 | PLCO-1725 |
| Development of Models for Predicting Clinical Outcomes from H&E Stained Whole Slide Images | Zoltan Szallasi | Boston Children's Hospital | PLCO | Nov 5, 2024 | PLCOI-1720 |
| The growing incidence of of colorectal cancer among those under 55 years age in The United States | Harrinique Deveaux | Florida State University | PLCO | Nov 5, 2024 | PLCO-1727 |
| Surrogate endpoints for cancer screening trials | Adam Brentnall | Queen Mary University of London | PLCO | Nov 5, 2024 | PLCO-1719 |
| Automatic Gleason Grading to Predict Survival | Anne Martel | Sunnybrook Research Institute | PLCO | Oct 21, 2024 | PLCOI-1716 |
| An explainable liver disease screening-based machine learning model | Angélica Atehortúa | ISGlobal Barcelona Institute for Global Health | PLCO | Oct 17, 2024 | PLCO-1712 |
| AI-based Pan-Cancer Survival Outcome Prediction and Biomarker Discovery | Jana Lipkova | University of California, Irvine | PLCO | Oct 17, 2024 | PLCOI-1715 |
| Incorporating blood biomarker with self reported exercise in PLCO cohort | Ehsan Irajizad | University of Texas MD Anderson Cancer Center | PLCO | Oct 17, 2024 | PLCO-1710 |
| From physiology to pathology | Gabriela Epihova | University of Cambridge | PLCO | Oct 16, 2024 | PLCO-1711 |
| Use of Digital Pathology and Artificial Intelligence for Prostate Cancer Risk Stratification in the Post-Surgical Setting | Danielle Croucher | Artera Inc. | PLCO | Oct 11, 2024 | PLCOI-1703 |
| Evaluating risk factor-based strategies for oversampling of individuals at higher risk of cancer for bioscpecimen collection and prospective assessment of Multi-Cancer Detection assays | Filip Pirsl | National Cancer Institute | PLCO | Oct 11, 2024 | PLCO-1704 |
| Fairness of AI use in Healthcare | Stacy Amadi | Northwestern University School of Professional Studies | PLCO | Oct 11, 2024 | PLCO-1696 |
| Development of a Risk Analysis and Breast Cancer Education Application | Rumaisha Afiqah Taqiyya | Bandung Institute of Technology | PLCO | Oct 7, 2024 | PLCO-1698 |
| External Data Integration in Prostate Cancer Trials | Md Tuhin Sheikh | Arizona State University | PLCO | Oct 7, 2024 | PLCO-1694 |